V

Vimian Group AB
STO:VIMIAN

Watchlist Manager
Vimian Group AB
STO:VIMIAN
Watchlist
Price: 40.38 SEK 0.85% Market Closed
Market Cap: 20.9B SEK
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one VIMIAN stock under the Base Case scenario is 59.63 SEK. Compared to the current market price of 40.38 SEK, Vimian Group AB is Undervalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VIMIAN Relative Value
Base Case
59.63 SEK
Undervaluation 32%
Relative Value
Price
V
Worst Case
Base Case
Best Case

Valuation Multiples

4.9
P/S
P/S
Price to Sales
4.9
vs History
50
vs Industry
25
Median 3Y
4.5
Median 5Y
4.9
Industry
2.2
Forward
4.3
More Details
98.7
P/E
P/E
Price to Earnings
98.7
vs History
46
vs Industry
4
Median 3Y
99
Median 5Y
97.1
Industry
21.7
Forward
31
More Details
29.7
P/OCF
P/OCF
Price to OCF
29.7
vs History
70
vs Industry
10
Median 3Y
33.8
Median 5Y
40.6
Industry
13.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
11
Median 3Y
9.1
Median 5Y
10.7
Industry
19.7
More Details
2.8
P/B
P/B
Price to Book Value
2.8
vs History
46
vs Industry
31
Median 3Y
2.6
Median 5Y
2.7
Industry
2.1
More Details
5.3
EV/S
EV/S
Enterprise Value to Sales
5.3
vs History
50
vs Industry
22
Median 3Y
5
Median 5Y
5.3
Industry
2.3
Forward
4.7
More Details
7.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.7
vs History
62
vs Industry
26
Median 3Y
7.8
Median 5Y
9
Industry
4.8
More Details
40.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
40.1
vs History
56
vs Industry
7
Median 3Y
40
Median 5Y
42.9
Industry
11.4
Forward
16.6
More Details
40.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
40.1
vs History
56
vs Industry
9
Median 3Y
40
Median 5Y
42.9
Industry
15.4
Forward
23.6
More Details
32.2
EV/OCF
EV/OCF
Enterprise Value to OCF
32.2
vs History
70
vs Industry
10
Median 3Y
36.8
Median 5Y
44.7
Industry
13.7
More Details
40.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
40.9
vs History
64
vs Industry
9
Median 3Y
45.8
Median 5Y
57.4
Industry
17.2
More Details
2
EV/IC
EV/IC
Enterprise Value to IC
2
vs History
40
vs Industry
36
Median 3Y
1.8
Median 5Y
2
Industry
1.8
More Details

Multiples Across Competitors

VIMIAN Competitors Multiples
Vimian Group AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Vimian Group AB
STO:VIMIAN
21.2B SEK 4.9 98.7 40.1 40.1
CH
Alcon AG
SIX:ALC
34.7B CHF 4.3 37.9 17.5 33
JP
Hoya Corp
TSE:7741
5.8T JPY 6.7 28.6 17.6 21
DK
Coloplast A/S
CSE:COLO B
138.1B DKK 5 30.4 17.5 20.7
US
Align Technology Inc
NASDAQ:ALGN
13.3B USD 3.3 32.4 15.4 19
UK
ConvaTec Group PLC
LSE:CTEC
5.8B GBP 3.4 41 210 343.5
CH
Ypsomed Holding AG
SIX:YPSN
5.5B CHF 7.4 63.1 30.4 51.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
45.6B CNY 13 32.7 28.2 28.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.4B USD 3.9 44.4 20.5 35.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.5B USD 3.6 21.5 9.9 11.3
KR
HLB Inc
KOSDAQ:028300
7T KRW 94 -37.2 -66.1 -62.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
V
Vimian Group AB
STO:VIMIAN
Average EV/EBITDA: 40.7
40.1
23%
1.7
CH
Alcon AG
SIX:ALC
17.5
10%
1.7
JP
Hoya Corp
TSE:7741
17.6
9%
2
DK
Coloplast A/S
CSE:COLO B
17.5
9%
1.9
US
Align Technology Inc
NASDAQ:ALGN
15.4
15%
1
UK
ConvaTec Group PLC
LSE:CTEC
210
11%
19.1
CH
Ypsomed Holding AG
SIX:YPSN
30.4
31%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
28.2
18%
1.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
20.5
12%
1.7
US
Lantheus Holdings Inc
NASDAQ:LNTH
9.9
21%
0.5
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -66.1 N/A N/A

See Also

Summary
VIMIAN intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIMIAN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIMIAN stock valuation using valuation multiples.
Wall Street Estimates
VIMIAN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIMIAN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 263,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.